These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17485328)

  • 1. TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.
    Blanco-Colio LM; Martín-Ventura JL; Munoz-Garcia B; Moreno JA; Meilhac O; Ortiz A; Egido J
    Front Biosci; 2007 May; 12():3648-55. PubMed ID: 17485328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TWEAK and Fn14 in tumor biology.
    Winkles JA; Tran NL; Brown SA; Stains N; Cunliffe HE; Berens ME
    Front Biosci; 2007 Jan; 12():2761-71. PubMed ID: 17127278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
    Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
    J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
    Wiley SR; Winkles JA
    Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB.
    Hénaut L; Sanz AB; Martin-Sanchez D; Carrasco S; Villa-Bellosta R; Aldamiz-Echevarria G; Massy ZA; Sanchez-Nino MD; Ortiz A
    Cell Death Dis; 2016 Jul; 7(7):e2305. PubMed ID: 27441657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.
    Tarín C; Fernández-Laso V; Sastre C; Madrigal-Matute J; Gómez M; Zaragoza C; Egido J; Burkly LC; Martín-Ventura JL; Blanco-Colio LM
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tweak and FN14 in central nervous system health and disease.
    Yepes M
    Front Biosci; 2007 May; 12():2772-81. PubMed ID: 17485258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.
    Campbell S; Michaelson J; Burkly L; Putterman C
    Front Biosci; 2004 Sep; 9():2273-84. PubMed ID: 15353286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.
    Jain M; Jakubowski A; Cui L; Shi J; Su L; Bauer M; Guan J; Lim CC; Naito Y; Thompson JS; Sam F; Ambrose C; Parr M; Crowell T; Lincecum JM; Wang MZ; Hsu YM; Zheng TS; Michaelson JS; Liao R; Burkly LC
    Circulation; 2009 Apr; 119(15):2058-68. PubMed ID: 19349318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A further TWEAK to multiple sclerosis pathophysiology.
    Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
    Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK, a multifunctional cytokine in kidney injury.
    Sanz AB; Sanchez-Niño MD; Ortiz A
    Kidney Int; 2011 Oct; 80(7):708-18. PubMed ID: 21697814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.
    Brown SA; Hanscom HN; Vu H; Brew SA; Winkles JA
    Biochem J; 2006 Jul; 397(2):297-304. PubMed ID: 16526941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAKing renal injury.
    Sanz AB; Moreno JA; Sanchez-Nino MD; Ucero AC; Benito A; Santamaria B; Justo P; Izquierdo MC; Egido J; Blanco-Colio LM; Ortiz A
    Front Biosci; 2008 Jan; 13():580-9. PubMed ID: 17981571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No end in site: TWEAK/Fn14 activation and autoimmunity associated- end-organ pathologies.
    Zheng TS; Burkly LC
    J Leukoc Biol; 2008 Aug; 84(2):338-47. PubMed ID: 18483204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
    Xu WD; Zhao Y; Liu Y
    Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.
    Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS
    J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.
    Tajrishi MM; Zheng TS; Burkly LC; Kumar A
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):215-25. PubMed ID: 24444596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.